The company was founded in 2000 and it is professional engaged in new drug preclinical safety and efficacy evaluation of services. Company formed by overseas returnees from more than 380 people at the core of talent team, with seven CFDA review of new drugs, and the United States SQARQAP - GLP certificate of experts, AAALAC international experts, as well as the domestic well-known toxicity pathology expert and nearly 40 professional and technical team.
With 16000 square meters of animal experimental facilities that meet the GLP specification, the safety test of experimental animals based on rats, mice, rabbits, dogs and monkeys can be carried out, and 130 trials can be carried out simultaneously.
The company is open to the domestic and international new drug research and development institutions and enterprises, to undertake chemical medicine, antibodies, vaccines, biological macromolecules, such as traditional Chinese medicine new drug efficacy and safety study technical service, with the FDA approved data acquisition system (Pristima ®), can provide customers with the CFDA and FDA of bilateral personal service, at present, has completed more than 30 a declaration for the FDA, new drug varieties has entered a phase III clinical trials.
With its high quality and fast services, the company has established a good reputation, and has established long-term and stable cooperative relationship with the top 50 companies in China and the top 20 enterprises in the world.
Familiar with Watson Pristima software;
Working experience with ICMS, IrDA test and U test；
Willing to learn and take over new things or challenge tasks;
High responsibility, be diligence and self-starter.